How Robot Surgery Launch At JNJ Has Changed Its Investment Story
Johnson & Johnson has completed the first commercial installation of its OTTAVA robotic surgical system at Memorial Hermann-Texas Medical Center and reported Phase 4 TREMFYA data showing clinically meaningful improvements in psoriatic arthritis with axial involvement. The OTTAVA launch and TREMFYA results both speak directly to Johnson & Johnson’s push to strengthen MedTech execution while deepening its immunology d…
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
